Lotus Pharmaceutical Co., Ltd.

TWSE:1795 Stock Report

Market Cap: NT$85.4b

Lotus Pharmaceutical Dividend

Dividend criteria checks 1/6

Lotus Pharmaceutical is a dividend paying company with a current yield of 1.09% that is well covered by earnings.

Key information

1.1%

Dividend yield

23%

Payout ratio

Industry average yield1.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per shareNT$15.52
Dividend yield forecast in 3Y2.4%

Recent dividend updates

Recent updates

Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?

Apr 24
Is Lotus Pharmaceutical (TWSE:1795) Using Too Much Debt?

Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price

Apr 09
Benign Growth For Lotus Pharmaceutical Co., Ltd. (TWSE:1795) Underpins Its Share Price

Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals

Mar 22
Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively

Apr 04
These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively

Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 09
Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?

Feb 11
Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?

Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?

Jan 21
Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?

Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?

Dec 31
Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?

I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease

Dec 10
I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease

Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next

Nov 19
Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, 1795 has been paying a dividend for less than 10 years.

Growing Dividend: 1795's dividend payments have increased, but the company has only paid a dividend for 3 years.


Dividend Yield vs Market

Lotus Pharmaceutical Dividend Yield vs Market
How does 1795 dividend yield compare to the market?
SegmentDividend Yield
Company (1795)1.1%
Market Bottom 25% (TW)1.8%
Market Top 25% (TW)4.5%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast in 3 Years (1795)2.4%

Notable Dividend: 1795's dividend (1.09%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.78%).

High Dividend: 1795's dividend (1.09%) is low compared to the top 25% of dividend payers in the TW market (4.48%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (23.3%), 1795's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 1795 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.